Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of screening, brief intervention, and referral to treatment in the perinatal period.
Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, Creanga AA. Wright TE, et al. Am J Obstet Gynecol. 2016 Nov;215(5):539-547. doi: 10.1016/j.ajog.2016.06.038. Epub 2016 Jul 1. Am J Obstet Gynecol. 2016. PMID: 27373599 Review.
Premenstrual disorders.
Yonkers KA, Simoni MK. Yonkers KA, et al. Am J Obstet Gynecol. 2018 Jan;218(1):68-74. doi: 10.1016/j.ajog.2017.05.045. Epub 2017 May 29. Am J Obstet Gynecol. 2018. PMID: 28571724 Review.
Evidence-Based Treatments for Premenstrual Disorders.
Yonkers KA, Simoni M. Yonkers KA, et al. Am J Obstet Gynecol. 2018 Aug;219(2):215-216. doi: 10.1016/j.ajog.2018.04.018. Epub 2018 Apr 16. Am J Obstet Gynecol. 2018. PMID: 29673568 No abstract available.
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Yonkers KA, et al. Obstet Gynecol. 2005 Sep;106(3):492-501. doi: 10.1097/01.AOG.0000175834.77215.2e. Obstet Gynecol. 2005. PMID: 16135578 Clinical Trial.
Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale.
Yonkers KA, Gotman N, Kershaw T, Forray A, Howell HB, Rounsaville BJ. Yonkers KA, et al. Obstet Gynecol. 2010 Oct;116(4):827-33. doi: 10.1097/AOG.0b013e3181ed8290. Obstet Gynecol. 2010. PMID: 20859145 Free PMC article. Clinical Trial.
Venlafaxine in the treatment of premenstrual dysphoric disorder.
Freeman EW, Rickels K, Yonkers KA, Kunz NR, McPherson M, Upton GV. Freeman EW, et al. Obstet Gynecol. 2001 Nov;98(5 Pt 1):737-44. doi: 10.1016/s0029-7844(01)01530-7. Obstet Gynecol. 2001. PMID: 11704162 Clinical Trial.
Differences in symptom scores and health outcomes in premenstrual syndrome.
Borenstein JE, Dean BB, Leifke E, Korner P, Yonkers KA. Borenstein JE, et al. J Womens Health (Larchmt). 2007 Oct;16(8):1139-44. doi: 10.1089/jwh.2006.0230. J Womens Health (Larchmt). 2007. PMID: 17937566
Health and economic impact of the premenstrual syndrome.
Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dickerson V, Yonkers KA. Borenstein JE, et al. J Reprod Med. 2003 Jul;48(7):515-24. J Reprod Med. 2003. PMID: 12953326
Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L. Halbreich U, et al. Obstet Gynecol. 2002 Dec;100(6):1219-29. doi: 10.1016/s0029-7844(02)02326-8. Obstet Gynecol. 2002. PMID: 12468166 Clinical Trial.
145 results
Jump to page
Feedback